Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine for Pulmonary Vein Isolation Evaluation (APPLE)
NCT01932112Phase 3Completed
- Start
- Nov 2012
- Primary completion
- Apr 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, open-label trial of adenosine in Atrial fibrillation (AFib). Primary endpoint: Reconnection of Pulmonary Vein Electrogram After Adenosine Infusion at 5 months. Started Nov 2012; status: completed.
02
Drugs
adenosine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01932112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01932112.